BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30519883)

  • 1. 6,7-Dehydroroyleanone diterpene derived from Tetradenia riparia essential oil modulates IL-4/IL-12 release by macrophages that are infected with Leishmania amazonensis.
    Terron-Monich MS; Demarchi IG; da Silva PRF; Ramos-Milaré ÁCFH; Gazim ZC; Silveira TGV; Lonardoni MVC
    Parasitol Res; 2019 Jan; 118(1):369-376. PubMed ID: 30519883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileishmanial activity of essential oil and 6,7-dehydroroyleanone isolated from Tetradenia riparia.
    Demarchi IG; Thomazella MV; de Souza Terron M; Lopes L; Gazim ZC; Cortez DA; Donatti L; Aristides SM; Silveira TG; Lonardoni MV
    Exp Parasitol; 2015 Oct; 157():128-37. PubMed ID: 26116864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileishmanial and immunomodulatory effects of the essential oil from Tetradenia riparia (Hochstetter) Codd.
    Demarchi IG; Terron Mde S; Thomazella MV; Mota CA; Gazim ZC; Cortez DA; Aristides SM; Silveira TG; Lonardoni MV
    Parasite Immunol; 2016 Jan; 38(1):64-77. PubMed ID: 26615004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Mycobacterium tuberculosis activity of essential oil and 6,7-dehydroroyleanone isolated from leaves of Tetradenia riparia (Hochst.) Codd (Lamiaceae).
    Baldin VP; Scodro RBL; Lopes-Ortiz MA; de Almeida AL; Gazim ZC; Ferarrese L; Faiões VDS; Torres-Santos EC; Pires CTA; Caleffi-Ferracioli KR; Siqueira VLD; Cortez DAG; Cardoso RF
    Phytomedicine; 2018 Aug; 47():34-39. PubMed ID: 30166106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileishmanial activity of the essential oil from Tetradenia riparia obtained in different seasons.
    Cardoso BM; de Mello TF; Lopes SN; Demarchi IG; Lera DS; Pedroso RB; Cortez DA; Gazim ZC; Aristides SM; Silveira TG; Lonardoni MV
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):1024-34. PubMed ID: 26602873
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Rottini MM; Amaral ACF; Ferreira JLP; Oliveira ESC; Silva JRA; Taniwaki NN; Dos Santos AR; Almeida-Souza F; de Souza CDSF; Calabrese KDS
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham.
    de Medeiros Md; da Silva AC; Citó AM; Borges AR; de Lima SG; Lopes JA; Figueiredo RC
    Parasitol Int; 2011 Sep; 60(3):237-41. PubMed ID: 21421075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileishmanial activity of the essential oil from Bixa orellana.
    Monzote L; García M; Scull R; Cuellar A; Setzer WN
    Phytother Res; 2014 May; 28(5):753-8. PubMed ID: 23983115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytocidal effects of the essential oil from Croton cajucara (red sacaca) and its major constituent 7- hydroxycalamenene against Leishmania chagasi.
    Rodrigues IA; Azevedo MM; Chaves FC; Bizzo HR; Corte-Real S; Alviano DS; Alviano CS; Rosa MS; Vermelho AB
    BMC Complement Altern Med; 2013 Oct; 13():249. PubMed ID: 24088644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Leishmania activity of essential oil of Myracrodruon urundeuva (Engl.) Fr. All.: Composition, cytotoxity and possible mechanisms of action.
    Carvalho CE; Sobrinho-Junior EP; Brito LM; Nicolau LA; Carvalho TP; Moura AK; Rodrigues KA; Carneiro SM; Arcanjo DD; Citó AM; Carvalho FA
    Exp Parasitol; 2017 Apr; 175():59-67. PubMed ID: 28189487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis.
    Monzote L; Montalvo AM; Almanonni S; Scull R; Miranda M; Abreu J
    Chemotherapy; 2006; 52(3):130-6. PubMed ID: 16636536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Thymus capitellatus volatile extract, 1,8-cineole and borneol against Leishmania species.
    Machado M; Dinis AM; Santos-Rosa M; Alves V; Salgueiro L; Cavaleiro C; Sousa MC
    Vet Parasitol; 2014 Feb; 200(1-2):39-49. PubMed ID: 24365244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity and anti-Leishmania amazonensis activity of Citrus sinensis leaf extracts.
    Garcia AR; Amaral ACF; Azevedo MMB; Corte-Real S; Lopes RC; Alviano CS; Pinheiro AS; Vermelho AB; Rodrigues IA
    Pharm Biol; 2017 Dec; 55(1):1780-1786. PubMed ID: 28524774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro leishmanicidal activity of monoterpenes present in two species of Protium (Burseraceae) on Leishmania amazonensis.
    Santana RC; Rosa ADS; Mateus MHDS; Soares DC; Atella G; Guimarães AC; Siani AC; Ramos MFS; Saraiva EM; Pinto-da-Silva LH
    J Ethnopharmacol; 2020 Sep; 259():112981. PubMed ID: 32442591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral treatment with the essential oil from Chenopodium ambrosioides against cutaneous leishmaniasis in BALB/c mice, caused by Leishmania amazonensis.
    Monzote L; García M; Montalvo AM; Linares R; Scull R
    Forsch Komplementmed; 2009 Oct; 16(5):334-8. PubMed ID: 19887812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grandiflorenic acid promotes death of promastigotes via apoptosis-like mechanism and affects amastigotes by increasing total iron bound capacity.
    Bortoleti BTDS; Gonçalves MD; Tomiotto-Pellissier F; Miranda-Sapla MM; Assolini JP; Carloto ACM; de Carvalho PGC; Cardoso ILA; Simão ANC; Arakawa NS; Costa IN; Conchon-Costa I; Pavanelli WR
    Phytomedicine; 2018 Jul; 46():11-20. PubMed ID: 30097110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
    Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
    Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway.
    Macedo SR; de Figueiredo Nicolete LD; Ferreira Ados S; de Barros NB; Nicolete R
    Int Immunopharmacol; 2015 Sep; 28(1):554-9. PubMed ID: 26218282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
    da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
    Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.